Role of Naloxone in Opioid Overdose Fatality Prevention; Public Workshop; Request for Comments

RIN

—

Last modified

Sep 11, 2015

Comment window

closed 3983d ago

American Pharmacists Association (APhA) filings

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Sep 11, 2015 and Sep 11, 2015. 11 other organizations filed here. The comment window closed 3983d ago.

What American Pharmacists Association (APhA) filed (1)

Sep 11, 2015· Comment from National Alliance of State Pharmacy Associations and American Pharmacists Association· FDA-2011-N-0802-0046

Please see the attached PDF for our comments submitted in collaboration with the American Pharmacists Association. Also, the National Alliance of State Pharmacy Associations would like to again express our appreciation for the opportunity to participate in and serve as a panelist at the FDA meeting: Exploring Naloxone Uptake and Use. Thank you.

View on regulations.gov →

Abstract

2012, 2015 Public Meeting; Request for Comments

View on regulations.gov →

Co-filers (11)

See everyone who commented →

American Pharmacists Association (APhA)THIS ORG
1 filing · confidence 97%
Drug Policy Alliancetrade assoc.
2 filings · confidence 85%
Harm Reduction Coalitiontrade assoc.
2 filings · confidence 85%
Addiction Recovery Council of Virginiatrade assoc.
1 filing · confidence 85%
American Association of Nurse Anesthetiststrade assoc.
1 filing · confidence 85%
American Society of Addiction Medicinetrade assoc.
1 filing · confidence 85%
International Association of Fire Chiefstrade assoc.
1 filing · confidence 85%
National Alliance for Medication-Assisted Recoverytrade assoc.
1 filing · confidence 85%
National Alliance of State & Territorial AIDS Directorstrade assoc.
1 filing · confidence 85%
Northeastern University School of Lawunverified attribution
1 filing · confidence 70%
Open Society Foundationstrade assoc.
1 filing · confidence 85%
University of California-San Diegounverified attribution
1 filing · confidence 70%